Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2011, Article ID 450743, 5 pages
http://dx.doi.org/10.1155/2011/450743
Case Report

Teratoma with Malignant Transformation: A Case Report with Pathological, Cytogenetic, and Immunohistochemistry Analysis

1Department of Internal Medicine, Section of Oncology-Hematology, University of Nebraska Medical Center, Omaha, NE 68198-7680, USA
2Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198-6495, USA

Received 2 March 2011; Accepted 20 April 2011

Academic Editor: Luca Sangiorgi

Copyright © 2011 Jue Wang and Syed A. Jaffar Kazmi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Motzer, A. Amsterdam, V. Prieto et al., “Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors,” Journal of Urology, vol. 159, no. 1, pp. 133–138, 1998. View at Google Scholar · View at Scopus
  2. C. V. Comiter, A. S. Kibel, J. P. Richie, M. R. Nucci, and A. A. Renshaw, “Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases,” Journal of Urology, vol. 159, no. 3, pp. 859–863, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Athanasiou, D. Vanel, O. El Mesbahi, C. Theodore, and K. Fizazi, “Non-germ cell tumours arising in germ cell tumours (teratoma with malignant transformation) in men: CT and MR findings,” European Journal of Radiology, vol. 69, no. 2, pp. 230–235, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. T. Ahmed, G. J. Bosl, and S. I. Hajdu, “Teratoma with malignant transformation in germ cell tumors in men,” Cancer, vol. 56, no. 4, pp. 860–863, 1985. View at Google Scholar · View at Scopus
  5. R. Corbett, R. Carter, D. MacVicar, A. Horwich, and R. Pinkerton, “Embryonal rhabdomyosarcoma arising in a germ cell tumour,” Medical and Pediatric Oncology, vol. 23, no. 6, pp. 497–502, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Rebischung, P. H. Cottu, A. Daban et al., “Germ-cell tumours containing non germ-cell neoplasms: teratoma with malignant transformation,” Urologic Oncology, vol. 6, no. 6, pp. 239–242, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. T. M. Ulbright, P. J. Loehrer, L. M. Roth et al., “The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases,” Cancer, vol. 54, no. 9, pp. 1824–1833, 1984. View at Google Scholar · View at Scopus
  8. J. S. Little Jr., R. S. Foster, T. M. Ulbright et al., “Unusual neoplasms detected in testis cancer patients undergoing post- chemotherapy retroperitoneal lymphadenectomy,” Journal of Urology, vol. 152, no. 4, pp. 1144–1149, 1994. View at Google Scholar · View at Scopus
  9. O. El Mesbahi, M. J. Terrier-Lacombe, C. Rebischung, C. Theodore, D. Vanel, and K. Fizazi, “Chemotherapy in patients with teratoma with malignant transformation,” European Urology, vol. 51, no. 5, pp. 1306–1311, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. A. C. Donadio, R. J. Motzer, D. F. Bajorin et al., “Chemotherapy for teratoma with malignant transformation,” Journal of Clinical Oncology, vol. 21, no. 23, pp. 4285–4291, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. A. Korfel, L. Fischer, H. D. Foss, H. C. Koch, and E. Thiel, “Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature,” Bone Marrow Transplantation, vol. 28, no. 8, pp. 787–789, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. http://www.clinicaltrials.gov/ct2/show/NCT00354744?term=ARST0531&rank=1.
  13. K. M. Kernek, M. Brunelli, T. M. Ulbright et al., “Flourescence in situ hybridization analysis of chromosome 12p in paraffin-embedded tissue is useful for establishing germ cell origin of metastatic tumors,” Modern Pathology, vol. 17, no. 11, pp. 1309–1313, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. J. J. Yeh, N. Y. Hsu, W. H. Hsu, C. H. Tsai, C. C. Lin, and J. A. Liang, “Comparison of chemotherapy response with P-glycoprotein, multidrug resistance-related protein-1, and lung resistance-related protein expression in untreated small cell lung cancer,” Lung, vol. 183, no. 3, pp. 177–183, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. K. Yoh, G. Ish II, T. Yokose et al., “Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer,” Clinical Cancer Research, vol. 10, no. 5, pp. 1691–1697, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. E. Diestra, E. Condom, X. G. del Muro et al., “Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications,” Journal of Urology, vol. 170, no. 4, part 1, pp. 1383–1387, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. G. Bepler, I. Kusmartseva, S. Sharma et al., “RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 24, no. 29, pp. 4731–4737, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. T. Fukushima, H. Takeshima, and H. Kataoka, “Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT,” Anticancer Research, vol. 29, no. 11, pp. 4845–4854, 2009. View at Google Scholar · View at Scopus
  19. A. Paradiso, G. Simone, S. Petroni et al., “Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients,” British Journal of Cancer, vol. 82, no. 3, pp. 560–567, 2000. View at Google Scholar · View at Scopus
  20. M. L. Rothenberg, “Topoisomerase I inhibitors: review and update,” Annals of Oncology, vol. 8, no. 9, pp. 837–855, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. M. S. Braun, S. D. Richman, P. Quirke et al., “Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial,” Journal of Clinical Oncology, vol. 26, no. 26, p. 4363, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. V. Durbecq, M. Paesmans, F. Cardoso et al., “Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel,” Molecular Cancer Therapeutics, vol. 3, no. 10, pp. 1207–1214, 2004. View at Google Scholar · View at Scopus